1. Home
  2. COMP vs TECH Comparison

COMP vs TECH Comparison

Compare COMP & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Compass Inc.

COMP

Compass Inc.

HOLD

Current Price

$11.75

Market Cap

8.8B

Sector

Technology

ML Signal

HOLD

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

HOLD

Current Price

$71.32

Market Cap

9.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COMP
TECH
Founded
2012
1976
Country
United States
United States
Employees
3200
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
9.1B
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
COMP
TECH
Price
$11.75
$71.32
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
11
Target Price
$11.80
$71.82
AVG Volume (30 Days)
15.4M
7.6M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
0.62%
EPS Growth
67.74
N/A
EPS
0.03
0.81
Revenue
$6,961,600,000.00
$1,219,635,000.00
Revenue This Year
$90.43
$2.49
Revenue Next Year
$8.63
$6.40
P/E Ratio
$398.00
$87.85
Revenue Growth
23.67
5.23
52 Week Low
$6.37
$43.20
52 Week High
$13.96
$72.16

Technical Indicators

Market Signals
Indicator
COMP
TECH
Relative Strength Index (RSI) 61.68 76.75
Support Level $10.17 $57.46
Resistance Level $13.54 N/A
Average True Range (ATR) 0.68 0.94
MACD -0.01 0.32
Stochastic Oscillator 60.77 99.59

Price Performance

Historical Comparison
COMP
TECH

About COMP Compass Inc.

Compass Inc provides an end-to-end platform that empowers residential real estate agents to deliver exceptional service to seller and buyer clients. The platform includes an integrated suite of cloud-based software for customer relationship management, marketing, client service and other critical functionality, all custom-built for the real estate industry and enabling core brokerage services. Business operations are conducted in the United States and earn revenue domestically.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: